SADDLE RIVER, N.J. & SAN DIEGO--(BUSINESS WIRE)--PDI, Inc. (NASDAQ:PDII), and Sequenom Center for Molecular Medicine, LLC (SCMM), a wholly owned subsidiary of Sequenom, Inc. (NASDAQ:SQNM) announced today that PDI has been selected to provide the sales infrastructure to launch and commercialize SCMM’s noninvasive prenatal genetic screening tests based on its SEQureDx™ technology.
